Clinical Edge Journal Scan

Gastric cancer: First-degree relatives show high prevalence of precancer lesions


 

Key clinical point: First-degree relatives of patients with gastric cancer show a high prevalence of preneoplastic lesions (PNL).

Major finding: The prevalence of PNL, atrophic gastritis, and intestinal metaplasia in first-degree relatives of gastric cancer patients were 86.4%, 82.7%, and 54.5%, respectively. The incidence of PNL was not significantly associated with sex (odds ratio [OR] 3.10; 95% confidence interval [CI] 1.00-9.64), age (OR 0.74; 95% CI, 0.26-2.14), and Helicobacter pylorii infection (OR 0.58; 95% CI 0.12-2.77). The advanced stages of Operative Link on Gastritis Assessment and Operative Link on Gastritis/Intestinal-Metaplasia Assessment were verified in 18.0% and 16.3% of the first-degree relatives, respectively.

Study details: This was a cross-sectional study including 110 first-degree relatives of patients with gastric cancer.

Disclosures: This study was partially supported by CONICYT, Chile. The authors declared no conflicts of interest.

Source: Sotelo S et al. Prevalence of gastric preneoplastic lesions in first-degree relatives of patients with gastric cancer: A cross-sectional study. J Gastrointest Cancer. 2022 (Apr 30). Doi: 10.1007/s12029-022-00827-x

Recommended Reading

Study shows link between dairy consumption and cancer
MDedge Hematology and Oncology
NeoChemo preserves rectum in half of patients with rectal cancer
MDedge Hematology and Oncology
Gallstone disease may be a harbinger of pancreatic cancer
MDedge Hematology and Oncology
Stroke in the young: Cancer in disguise?
MDedge Hematology and Oncology
Jury is in? Survival benefit with lap surgery for rectal cancer
MDedge Hematology and Oncology
Improved cancer survival in states with ACA Medicaid expansion
MDedge Hematology and Oncology
AUA 2022: A report from the trenches
MDedge Hematology and Oncology
Advanced gastric cancer: Taxane-based chemotherapy regimen improves outcomes
MDedge Hematology and Oncology
Serum pepsinogen is associated with gastric cancer risk
MDedge Hematology and Oncology
Gastric cancer: Oxaliplatin and cisplatin confer similar survival in elderly patients
MDedge Hematology and Oncology